GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

That’s the most prevalent right now, and then we also have the RSV virus, which is about 20.9%,” Dr. Khan explained that seasonal viruses are beginning to tick up again. RSV is a virus that ...

Oct. 31, 2024 — Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses.

The immunization helps prevent serious infections caused by the virus. As a second option, pregnant people can protect their newborns from RSV by getting Abrysvo® (RSVpreF vaccine) during pregnancy.

Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

EvolutionaryScale can design proteins with desired properties according to prompts by simultaneously evolving sequence, ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

It is an illness that occurs primarily in children younger than 2 years old. It most commonly occurs in babies between 3 and 6 months old, with respiratory syncytial virus (RSV) being the primary ...

Here’s how it works. Space can be a wondrous place, and we've got the pictures to prove it! Take a look at our favorite space pictures here, and if you're wondering what happened to today in ...